Oncology Research Hub

Explore cutting-edge studies in tumor biology, molecular pathways, and clinical breakthroughs

Research Articles

Breaking the Resistance: How a Novel CDK Inhibitor Offers Hope for Blood Cancer Patients

A comprehensive look at the phase 1 study of voruciclib for relapsed/refractory AML and B-cell malignancies, exploring CDK9 inhibition as a strategy to overcome treatment resistance.

Lillian Cooper
Oct 11, 2025

Popular Articles

Research Tags